The financing was led by Lapam Capital, with participation from Frees Fund and Riverhead Capital.
Chronic kidney disease (CKD) is a progressive condition that begins with tissue damage and gradually leads to loss of kidney ...
A newly engineered antibody can penetrate kidney cysts and interrupt the growth signals that drive polycystic kidney disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results